|
Re: Shorts
|
2
|
Resverlogix Corp.
|
Feb 10, 2024 09:38AM
|
|
Re: Little confused, any insight would be great
|
4
|
Resverlogix Corp.
|
Mar 04, 2024 04:02PM
|
|
Re: Little confused, any insight would be great
|
3
|
Resverlogix Corp.
|
Mar 04, 2024 05:38PM
|
|
Re: Little confused, any insight would be great
|
2
|
Resverlogix Corp.
|
Mar 04, 2024 08:22PM
|
|
Re: Little confused, any insight would be great
|
5
|
Resverlogix Corp.
|
Mar 04, 2024 08:44PM
|
|
Re: Annual Financial Reporting
|
5
|
Zenith Epigenetics
|
Mar 22, 2024 03:15PM
|
|
Re: Interim Financial .... Interim MD&A .... Reporting
|
7
|
Zenith Epigenetics
|
Apr 07, 2024 11:51PM
|
|
Re: What happened to our renal trial from 2017???
|
6
|
Resverlogix Corp.
|
Apr 11, 2024 10:30AM
|
|
Re: Alpine Immune buyout by Vertex
|
8
|
Zenith Epigenetics
|
Apr 11, 2024 11:23AM
|
|
Re: What happened to our renal trial from 2017???
|
7
|
Resverlogix Corp.
|
Apr 12, 2024 01:17PM
|
|
Re: Secured $6M Convertable Debenture
|
4
|
Resverlogix Corp.
|
Apr 18, 2024 11:32AM
|
|
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
|
3
|
Zenith Epigenetics
|
May 19, 2024 10:21PM
|
|
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
|
2
|
Zenith Epigenetics
|
May 20, 2024 02:03PM
|
|
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
|
1
|
Zenith Epigenetics
|
May 20, 2024 11:26PM
|
|
Notice of 2024 Annual Meeting Delayed?
|
2
|
Resverlogix Corp.
|
May 23, 2024 11:19AM
|
|
Re: Notice of 2024 Annual Meeting Delayed?
|
2
|
Resverlogix Corp.
|
May 23, 2024 11:28AM
|
|
A Special Meeting of Shareholders?
|
3
|
Resverlogix Corp.
|
May 28, 2024 08:57PM
|
|
Re: A Special Meeting of Shareholders?
|
6
|
Resverlogix Corp.
|
May 28, 2024 11:33PM
|
|
Re: A Special Meeting of Shareholders?
|
|
Resverlogix Corp.
|
May 29, 2024 12:43PM
|
|
Re: A Special Meeting of Shareholders?
|
1
|
Resverlogix Corp.
|
May 30, 2024 09:07AM
|
